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Distinct Differentiation Programs 
Triggered by IL-6 and LPS in Teleost 
IgM+ B Cells in The Absence of 
Germinal Centers
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Although originally identified as a B cell differentiation factor, it is now known that mammalian 
interleukin-6 (IL-6) only regulates B cells committed to plasma cells in response to T-dependent (TD) 
antigens within germinal centers (GCs). Even though adaptive immunity is present in teleost fish, 
these species lack lymph nodes and GCs. Thus, the aim of the present study was to establish the role of 
trout IL-6 on B cells, comparing its effects to those induced by bacterial lipopolysaccharide (LPS). We 
demonstrate that the effects of teleost IL-6 on naïve spleen B cells include proliferation, activation of 
NF-κB, increased IgM secretion, up-regulation of Blimp1 transcription and decreased MHC-II surface 
expression that point to trout IL-6 as a differentiation factor for IgM antibody-secreting cells (ASCs). 
However, LPS induced the secretion of IgM without up-regulating Blimp1, driving the cells towards 
an intermediate activation state in which antigen presenting mechanisms are elicited together with 
antibody secretion and expression of pro-inflammatory genes. Our results reveal that, in trout, IL-6 
is a differentiation factor for B cells, stimulating IgM responses in the absence of follicular structures, 
and suggest that it was after follicular structures appeared that this cytokine evolved to modulate TD 
responses within the GC.
The immune system comprises both innate and adaptive immune responses. While the innate immune system 
is genetically programmed to detect invariant features of invading microbes, the cells of the adaptive immune 
system, such as conventional B cells (B2) and T cells, detect specific epitopes through somatically recombined 
receptors. However, it is now recognized that both branches of immunity are highly interconnected and B cells 
also possess a certain capacity to directly sense and respond to pathogens though the expression of certain pattern 
recognition receptors (PRRs) or through the action of cytokines produced by cells of the innate immune system1. 
In general, conventional B cells are activated in response to T-dependent (TD) antigens within the lymphoid 
follicles and trigger the formation of germinal centers (GCs). These sites promote the close collaboration between 
proliferating antigen-specific B cells, T follicular helper cells, and the specialized follicular dendritic cells (DCs) 
that constitutively occupy the central follicular zones of secondary lymphoid organs. In this environment, 
B cells divide in response to antigens and acquire the capacity to differentiate into antibody-secreting cells (ASCs), 
reaching a terminal state of plasma cells or memory B cells, both of them with the capacity to secrete high affinity 
antibodies. This TD pathway provides a strong long-lived immunological memory, but is relative slow to occur. 
Thus, it must be integrated with additional T-independent (TI) pathways that mainly involve other B cell subsets 
such as B1 cells or marginal zone (MZ) B cells. These TI responses do not require cooperation from T cells, but 
instead are much more responsive to products secreted by cells of the innate immune system and have a greater 
capacity to directly recognize pathogens1.
Although evolutionarily jawed fish constitute the first group of animals in which adaptive immunity based on 
Ig receptors is present2, many structural immune peculiarities predict important functional differences between 
fish and mammalian B cells. The teleost spleen constitutes the main secondary immune organ in the absence of 
lymph nodes. However, the splenic white pulp is poorly developed in teleosts in comparison to mammals and 
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no GCs are apparent3. Regarding mucosal immunity, although fish B cells have been reported in surfaces such as 
gills, skin, digestive tract and nasal cavities4,5, they are scattered throughout the mucosa in disorganized lymphoid 
structures6. Additionally, fish contain only three immunoglobulin classes IgM, IgD and IgT (designated as IgZ 
in some species). IgT is a teleost fish-specific Ig that seems specialized in mucosal immunity7,8 and IgT+ B cells 
constitute a distinct linage7, thus no class switch recombination has ever been reported in fish. As a result, the 
lack of teleost follicular structures already anticipates that fish B cell responses best resemble mammalian extr-
afollicular responses. Consequently, teleost B cells share many features of mammalian B1 cells, as for example a 
high phagocytic capacity9,10, constitutive expression of many PRRs4,11 or expression of B1-specific cell markers12.
Interleukin 6 (IL-6) is a multi-functional cytokine produced by a wide range of cell types in the early stages 
of infection. IL-6 modulates a plethora of immune functions through a receptor composed of the restricted IL-6 
receptor chain (IL-6R) and a common signal transducer, gp13013. Although initially described as a B cell dif-
ferentiation factor14, it was later demonstrated that IL-6 is a potent growth and maturation factor only for cells 
that have already initiated a differentiation process towards plasma cells, but has minimal capacity to directly 
induce plasma cell differentiation15. Besides, IL-6 enhances antibody production of ASCs but only those that are 
antigen-specific, whereas non-specific ASCs are unresponsive to IL-616. Interestingly, the normal development of 
GCs is significantly altered in the absence of IL-617. Consequently, IL-6 deficiency significantly impairs early TD 
IgG production, but has no effect on IgM TI responses17,18. Thus, it has been postulated that IL-6 is predominantly 
involved in the maturation of TD plasma cells in the early stages of GC formation19. At a mucosal level, IL-6 also 
seems implicated in promoting IgA TD responses20. Strikingly, the number of B1-derived IgA-secreting cells 
significantly increases in the absence of IL-620, demonstrating that B1 cells are not regulated by this cytokine and 
can even be negatively affected by it. Despite this, IL-6 in combination with an anti-IgM antibody induces the 
expression of surface CD5 on conventional B2 cells that acquire phenotypic characteristics of B1 cells21.
Taking into account the main role of IL-6 on TD responses in mammals and the unique attributes of fish 
B cells, it is important to determine the effect of IL-6 on fish B cells, which we do here using the rainbow trout 
(Oncorhynchus mykiss) as a model. We compare the effects elicited by IL-6 to those triggered by lipopolysaccha-
ride (LPS). LPS, a protein-free endotoxin from the cell wall of Gram-negative bacteria, is the most extensively 
studied TI antigen in mammals and is directly recognized by B cells through low affinity B cell receptors (BCRs) 
and PRRs such as Toll like receptors (TLRs)22. LPS is not a mitogen for human B cells, since human B cells express 
neither TLR4 nor CD14, the two canonical ligands for Gram (− ) bacterial LPS23,24. In contrast, mice B cells 
express TLR4 and are polyclonally activated by it25. Interestingly, although TLR4 is thought to be absent from the 
genome of salmonid fish26, some effects of LPS on salmonid B cells have been reported27.
Our findings demonstrate that, in contrast to what occurs in mammals, B cells obtained from healthy unstim-
ulated trout respond to IL-6. The effects that IL-6 exerted on these IgM+ B cells included proliferation, activa-
tion of NF-κ B, increased IgM secretion, up-regulation of Blimp1 transcription, increased size and decreased 
MHC-II surface expression, all pointing to trout IL-6 as a differentiation factor for naïve IgM B cells towards 
ASCs. Interestingly, LPS also increased IgM secretion but the activation profile was very different to that elicited 
by IL-6, driving the IgM+ B cells towards a pro-inflammatory state. Additionally, IL-6 stimulated B cells mobilized 
more intracellular calcium in response to BCR cross-linking, demonstrating that IgM ASCs retain a functional 
BCR on the cell surface. Thus, our results demonstrate that in trout, where follicular structures have not yet been 
developed, IL-6 regulates IgM B cell responses. This suggests that the emergence of follicular structures marked a 
critical point in IL-6 evolution, acquiring a novel capacity to specifically regulate TD antibody responses.
Results
The IL-6 receptor complex is transcribed in IgM+ B cells from naïve fish that are activated by 
IL-6 stimulation. IL-6 exerts its biological activities through two molecules: the IL-6 receptor, IL-6Rα (also 
known as gp80 and CD130) and the associated signal transducer glycoprotein gp130. While IL-6Rα is important 
for ligand binding, gp130 is required for adequate intracellular signaling28. Prior to studying the effects of IL-6 
on naïve B cells in fish, we determined if these two molecules were constitutively transcribed in sorted naïve 
IgM+ B cells from spleen, blood and kidney, being this last organ the main hematopoietic tissue in fish. We found 
that IgM+ B cells from all three tissues constitutively transcribed IL-6Rα and gp130 at similar expression levels 
(Supplemental Figure S1A), suggesting that naïve B cells have the capacity to respond to IL-6. These results con-
trast those of mammals, where only activated B cells express IL-6R16,28.
To confirm that unstimulated B cells from trout are responsive to IL-6, we first examined the expression of 
SOCS3 and STAT3, two genes involved in the signaling of IL-6, in sorted IL-6-stimulated trout IgM+ B cells. Both 
SOCS3 and STAT3 were significantly up-regulated in IgM+ B cells in response to IL-6 stimulation (Supplemental 
Figure S1B), as previously reported in other IL-6-responsive cell types in trout29. LPS, on the other hand, induced 
the transcription of STAT3 but had no effect on SOCS3 mRNA levels (Supplemental Figure S1B). To further 
confirm these results and demonstrate a direct effect of IL-6 on IgM+ B cells, we sorted IgM+ cells and afterwards 
incubated them with IL-6 or LPS. After 1 h of incubation, the phosphorylation of STAT3 was confirmed through 
Western blot in response to IL-6 and LPS (Supplemental Figure S1C). These results confirm a direct effect of IL-6 
on IgM+ B cells.
IL-6 induces IgM+ cell proliferation. As already mentioned, mammalian IL-6 has no effect on naïve B 
cells, but has been shown to induce the proliferation of pre-B cells30 as well as plasmablasts31. In contrast, LPS is 
a potent inducer of B cell proliferation in mice and fish27,32. Thus, we compared the lymphoproliferative effects 
of LPS to those of IL-6 in trout splenocytes. Our results show that trout spleen IgM+ B cells significantly prolif-
erated in response to IL-6 (Fig. 1a,c), although at levels significantly lower than those elicited by LPS (Fig. 1a,c). 
When the percentage of IgM+ B cells was evaluated in these cultures without taking into account BrdU uptake, 
the percentage of IgM+ cells was quite similar in LPS- and IL-6-treated cultures, suggesting an additional positive 
www.nature.com/scientificreports/
3Scientific RepoRts | 6:30004 | DOI: 10.1038/srep30004
effect of IL-6 on B cell survival (Fig. 1b). The proliferative and survival effects observed were specific to IL-6 since 
another cytokine produced and tested in parallel, IL-4/13A, was unable to increase the number of trout IgM+ cells 
during the in vitro culture33.
Since in mammals IL-6 only activates B cells previously stimulated with TD antigens17,18, we also evaluated 
the potential synergistic effect of IL-6 on IgM+ B cell proliferation induced by a TD antigen (TNP-KLH) or a 
TI antigen (TNP-LPS). We performed this experiment because despite their lack of follicular structures, fish 
can orchestrate responses to TD antigens34, possibly through a mechanism that resembles rare extrafollicular 
TD responses reported in mammals35–37. For this, we incubated splenocytes with TNP-KLH or TNP-LPS in the 
presence or absence of IL-6 and evaluated the percentage of BrdU+/IgM+ B cells after 4 days. We observed that 
the addition of IL-6 could further enhance the proliferative effects provoked by TNP-LPS or TNP-KLH (Fig. 1d), 
indicating that, in trout, IL-6 can have regulatory effects on both TD and TI responses.
Figure 1. IL-6 and LPS elicit B cell proliferation and increased survival. Spleen leukocytes were incubated 
with IL-6 (200 ng/ml) or LPS (100 μ g/ml) for 3 days at 20 °C. After this time, BrdU was added to the cultures and 
incubated for a further 24 h. The percentage of proliferating (BrdU+) IgM+ B cells was determined as described in 
Material and Methods. (a) Percentage (mean + standard deviation) of proliferating IgM+ B cells (BrdU+/IgM+) 
after treatment with IL-6 and/or LPS (n = 6). (b) IgM+ B cell survival estimated as percentage of IgM+ cells 
(proliferating and non-proliferating cells) in cultures (mean + standard deviation) (n = 6). (c) Representative 
dot plots are shown. (d) Spleen leukocytes were stimulated with TNP-KLH (5 μ g/ml) or TNP-LPS (5 μ g/ml) in 
the presence or absence of IL-6 (200 ng/ml). The percentage of proliferating IgM+ cells was assessed as described 
above. Data are shown as the mean fold change relative to the control value for unstimulated controls + standard 
deviation (n = 5). Asterisks denote significant differences between cells treated with IL-6 or LPS and their 
corresponding controls and between IL-6 and LPS treated cells when indicated. * P < 0.05, * * P < 0.01.
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IL-6 up-regulates IgM secretion in naïve B cells. In mammals, IL-6 is unable to induce differentiation 
of naïve B cells towards plasmablasts on its own15. In contrast, the in vitro incubation of naïve splenic B cells with 
IL-6 was sufficient to induce the secretion of IgM, as verified in an ELISPOT assay (Fig. 2a,b). When this experi-
ment was carried out in previously immunized fish, IL-6 also increased the secretion of IgM, at levels significantly 
higher than those observed in non-immunized healthy trout (Supplemental Figure S2). As previously reported27, 
LPS also induced the secretion of IgM by trout B cells, however, our results suggest that the mechanisms through 
which IgM secretion is induced differ between IL-6 and LPS-stimulated B cells. At the transcript level, only IL-6 
up-regulated the transcription of Blimp1, a protein required for the development of ASCs and the maintenance of 
long-lived plasma cells38, while LPS had no effect (Fig. 2b). Interestingly, IL-6 also up-regulated the transcription 
of ACKR2, an atypical chemokine receptor specific for innate B cells39, while LPS showed no effect (Fig. 2b). Thus, 
Figure 2. IL-6 and LPS activate IgM secretion in naïve B cells. (a) ELISPOT analysis of IgM-secreting cells 
in splenocyte cultures treated with IL-6 (200 ng/ml), LPS (100 μ g/ml) or non-stimulated. Splenocytes were 
cultured for 3 days in ELISPOT plates previously coated with anti-trout IgM mAb (2 μ g/ml) in the presence or 
absence of the different stimuli. After incubation, cells were washed away and a biotinylated anti-trout IgM mAb 
(1 μ g/ml) was used to detect numbers of spot forming cells. Duplicates from a representative experiment (left) 
and quantification of spot forming cells (right) from 5 independent experiments are shown (mean + standard 
deviation). (b) Spleen leukocytes were incubated with media containing IL-6, LPS or control media alone for 24 h 
at 20 °C. After that time, IgM+ B cells were sorted using an anti-trout IgM mAb and RNA was extracted. Relative 
transcript expression of Blimp-1 and ACKR2 is shown (mean + standard deviation, n = 6). (c) Membrane IgM 
and total IgM expression of IgM+ cells after incubation with IL-6, LPS or control media for 24, 48 and 72 h. Mean 
fluorescence intensity (MFI) + standard deviation is shown (n = 9). (d) Dot plots and histograms showing the 
Forward scatter (FSC) from IgM+ B cells and BrdU+/IgM+ B cells incubated in the presence or absence of LPS 
or IL-6, from one representative experiment. Graphs showing FSC MFI values from 8 independent experiments 
(mean + standard deviation) are included next to the histograms for stimulated cultures. * P < 0.05, * * P < 0.01,  
* * * P < 0.001.
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our results demonstrate that, unlike mammalian IL-6, fish IL-6 is a differentiation factor for naïve B cells towards 
an ASC profile. On the other hand, LPS seems to induce the secretion of IgM in a Blimp1-independent fashion.
In mammals, the differentiation of B cells to plasma cells provokes a down-regulation of membrane Igs that 
completely loose the BCR when terminally differentiated40. However, recent reports have demonstrated that this 
seems to only be true for IgG plasma cells, since fully differentiated IgM or IgA-secreting plasma cells retain a 
functional BCR in the cell membrane41. In our studies, we observed that both IL-6 and LPS increased the levels of 
expression of total IgM in B cells (Fig. 2c), along with increased membrane IgM levels (Fig. 2c). Therefore, these 
IL-6 or LPS-induced plasmablasts retain and even up-regulate IgM levels in the cell surface while increasing their 
secretion of IgM, similar to mammalian IgM plasma cells. The secretion of IgM in response to LPS or IL-6 was 
associated with an increase in the size of IgM+ cells, as shown by increased forward side scatter (FSC) in stimu-
lated cells in comparison to control cells. This increase in size was significant when proliferating cells were ana-
lyzed (Fig. 2d) demonstrating that LPS and IL-6 induce the proliferation of IgM+ B cells and part of the progeny 
differentiate into ASCs that retain IgM on the cell surface.
IL-6 activates NF-κB in spleen IgM+ B cells. After binding to its receptor, IL-6 activates gene expression 
mainly through the STAT3 pathway28,42 and, in line with its pro-inflammatory nature, it has been shown to acti-
vate NF-κ B in intestinal epithelial cells43. Despite this, whether IL-6 activates NF-κ B in mammalian B cells has 
not been established. In mice, LPS induces a dual BCR/TLR-signaling by engaging TLR4 through the lipid A moi-
ety and the BCR through the polysaccharidic moiety44. As a result, both the canonical and non-canonical NF-κ B 
signaling pathways are activated in B cells in response to LPS. To determine whether IL-6 and LPS activate the 
NF-κ B signaling pathway in our system, we analyzed the translocation of the NF-κ B p65 subunit to the nucleus 
of IgM+ B cells using a quantitative imaging flow cytometry-based approach which we have used previously11. We 
observed a significant increase in the percentage of total splenocytes and IgM+ B cells in which p65 translocated 
to the nucleus in response to IL-6 and LPS in comparison with control cells, indicating that both stimuli activate 
the canonical NF-κ B pathway (Fig. 3a).
However, when the transcriptional activity of NF-κ B-dependent genes such as IL-1β 1, IL-8 or TNF-α 3 was 
studied, only LPS was capable of inducing a significant up-regulation of their mRNA levels (Fig. 3b). Similarly, 
differential effects of LPS and IL-6 in the transcriptional activation of antimicrobial peptides was also observed. 
While LPS up-regulated cathelicidin 1 (CATH1) mRNA levels (Fig. 3b) CATH2 was significantly up-regulated 
by both LPS and IL-6, although the effect of IL-6 was much stronger (Fig. 3b). Taken together, these results show 
that although IL-6 and LPS activate NF-κ B in IgM+ B cells, the downstream effects of this activation are different.
IL-6 and LPS-stimulated IgM+ B cells are predisposed for BCR-mediated calcium mobili-
zation. Anti-IgM stimulation of B cells mimics the recognition of a high affinity antigen by the BCR, 
Figure 3. Effect of IL-6 and LPS on NF-κB activation and transcription of pro-inflammatory and 
antimicrobial genes in B cells. (a) Translocation of NF-κ B to the nucleus in IgM+ splenocytes following 
stimulation with LPS (100 μ g/ml) or IL-6 (200 ng/ml) for 24 h. The mean percentages of NF-κ B translocation in 
total cells (upper panel) and IgM+ B cells (lower panel) from six independent experiments are shown. * * P < 0.01, 
* * * P < 0.001. (b) Spleen leukocytes were incubated with IL-6, LPS or control media alone for 24 h at 20 °C. The 
effect of IL-6 and LPS on the transcription of IL-1β 1, IL-8, TNF-α 3, cathelicidin-1 (CATH1), CATH2 and hepcidin 
was then studied in sorted IgM+ B cells from these cultures. The relative transcript expression (mean + standard 
deviation) of 6 independent experiments is shown. * P < 0.05, * * P < 0.01, * * * P < 0.001.
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consequently leading to a rapid increase of intracellular calcium45. This calcium mobilization plays an important 
role in B cell activation and is required for correct downstream signaling of the BCR45. Thus, we also studied the 
effect of anti-IgM cross-linking of the BCR in splenocyte cultures that had been previously stimulated with IL-6 
or LPS and compared them to those in non-stimulated control cells, given the fact that IL-6 or LPS-stimulated 
cells seem to retain their BCR. As expected, anti-IgM induced a rapid mobilization of intracellular calcium, and 
furthermore, the levels of calcium released upon anti-IgM stimulation were significantly higher in cells that had 
been previously stimulated with IL-6 or LPS (Fig. 4a,b). This stimulatory effect was observed after 24, 48 or 72 h of 
stimulation. Thus, our results reveal that IL-6 renders the cells more responsive to BCR engagement.
IL-6 down-regulates the surface expression of MHC-II in naïve trout B cells. The response of 
B cells against an antigen not only requires antigen binding to and signaling through the BCR but also the 
processing and presentation of the BCR-bound antigen to helper T cells in the context of MHC-II46. Thus, we 
also determined the effect of IL-6 or LPS stimulation on the levels of expression of surface MHC-II of naïve 
B cells using a specific anti-trout MHC-II antibody. We observed that IL-6 provoked a significant decrease of 
surface MHC-II expression that was detectable from 24 h post-stimulation up to 72 h post-stimulation (Fig. 5a). 
In contrast, LPS-stimulated B cells showed increased surface MHC-II levels at all time points studied (Fig. 5a). 
Along with this increase in MHC II levels, LPS also up-regulated the levels of transcription of two co-stimulatory 
molecules: CD80/86, a molecule with similar homologies to mammalian CD80 and CD8647, and CD83 (Fig. 5b). 
IL-6, on the other hand, had no effect on their transcription levels (Fig. 5b).
IL-6 has no effect on the phagocytic activity of IgM+ B cells. Since trout B cells have a potent phago-
cytic activity9, we also investigated whether IL-6 or LPS pre-stimulation of naïve IgM+ B cells could have an 
effect on their phagocytic activity. For this, splenocytes were incubated with IL-6 or LPS for different incubation 
periods, or left-unstimulated in the same conditions. Thereafter, 1 μ m polystyrene-based fluorescent beads were 
added to the cultures and after 3 h of incubation the phagocytic activity of IgM+ cells was determined in flow 
cytometry. We observed that while pre-stimulation of B cells with LPS significantly increased the percentage of 
phagocytic IgM+ B cells in spleen, pre-stimulation with IL-6 produced no effect (Fig. 6a,b).
IL-6 has a synergistic effect on antigen-specific IgM responses in vivo. Given the stimulatory 
effects observed for IL-6 on IgM+ B cells in vitro, we next investigated whether this stimulatory effect on naïve 
IgM+ B cells could also condition IgM responses elicited in vivo in response to a specific antigen. For this, we 
immunized fish with inactivated infectious pancreatic necrosis virus (IPNV) either alone or in combination with 
IL-6. Control groups treated with IL-6 alone or PBS were also included. The administration of IL-6 alone sig-
nificantly increased the number of IgM-secreting cells in the spleen at day 2, but no effect was observed in the 
following days (Fig. 7a). IPNV on its own was unable to increase the number of IgM-secreting cells in spleen or 
kidney when compared to controls, however when IPNV was combined with IL-6, the number of IgM-secreting 
cells significantly increased in spleen at day 6 post-immunization and in the kidney at day 2 post-immunization, 
when compared to controls or fish injected with IPNV alone (Fig. 7a). These positive effects of IL-6 on the num-
ber of ASCs elicited by IPNV, correlated with significantly increased IPNV-specific IgM titers in sera of fish 
injected with IPNV and IL-6 when compared to titers in fish injected with IPNV alone (Fig. 7b). Surprisingly, 
this increase in IPNV-specific IgM had no effect on total IgM titers (Fig. 7b) at the time point sampled (day 15 
post-immunization).
To get additional information on the antibodies present in the sera we also analyzed the titers of natural anti-
bodies against four classic antigens, BSA, galactosidase, phosphorylcholine and dsRNA (poly I:C) in the same 
Figure 4. IL-6 and LPS predispose IgM+ B cells to calcium mobilization after BCR cross-liking. Spleen 
leukocytes were incubated with IL-6 (200 ng/ml), LPS (100 μ g/ml) or control media alone for 24, 48 and 72 h 
at 20 °C. After the different incubation periods, cells were loaded with Fluo-3 AM (5 μ M final concentration), 
and its baseline emission was measured by flow cytometry for 30 s, and then stimulated with 0.5 ug/ml 
of Alexa 647 conjugated anti-IgM mAb. Fluorescence was then measured for a further 180 s. (a) Mean 
fluorescence intensity (MFI) plus standard deviation of intracellular Ca2+ levels (Fluo-3) in IgM+ B cells is 
shown (n = 6). * P < 0.05, * * P < 0.01, * * * P < 0.001. (b) Scatter plot showing Fluo-3 MFI levels in spleen  
IgM+ B cells after 48 h of incubation with the appropriate stimuli.
www.nature.com/scientificreports/
7Scientific RepoRts | 6:30004 | DOI: 10.1038/srep30004
groups. We observed a significant decrease in the titers of antibodies that bind these four antigens in all the groups 
treated with IL-6 or/and IPNV. Interestingly, at the same time that IL-6 significantly increased IPNV-specific IgM 
titers when compared to those elicited by IPNV alone (Fig. 7b), it decreased the amount of natural antibodies 
reactive against BSA or galactosidase in serum (Fig. 7b). Taken together, our results strongly suggest that when 
combined with an antigen in vivo, IL-6 preferentially activates antigen-specific B cells as occurs in mammals.
Discussion
Although mammalian IL-6 exclusively signals in antigen-experienced cells15, thus only affecting the outcome 
of switched antibody isotypes such as IgG or IgA18,19,48; a recent study reported that fugu (Takifugu rubripes) 
unstimulated B cells transcribe both IL-6Rα and gp130 and that the in vitro stimulation of blood leukocytes with 
IL-6 up-regulates IgM transcription levels42. These results suggest that fish B cells from healthy unstimulated fish 
could be responsive to IL-6. Hence, we decided to investigate further the capacity of IL-6 to regulate B cell activity 
in fish, using the rainbow trout as a model. Once we had verified that rainbow trout unstimulated IgM+ B cells 
also transcribe IL-6Rα and gp130, we examined the effects of IL-6 on different relevant functions of fish B cells. 
We compared the effects provoked by IL-6 to those elicited by LPS, since there is still some controversy about the 
degree to which trout cells respond to LPS. Although LPS stimulation was reported to increase IgM secretion and 
lymphocyte proliferation in trout27, TLR4 seems absent from salmonid genomes26. In this context, our studies 
would help to establish how, in the absence of follicular structures, fish IL-6 regulates the activity of IgM+ B cells. 
Furthermore, our results would provide additional evidence as to how teleost B cells respond to LPS.
LPS is a potent mitogen of B cells and the in vitro responses of these cells to LPS are very robust both in mice32 
and in fish49. In our experiments, LPS and IL-6 were both mitogenic for trout IgM+ cells. Although the prolifera-
tion levels in response to IL-6 were significantly lower than those observed for LPS, the percentage of viable IgM+ 
B cells in the cultures was similar in response to the different stimuli and significantly higher than the percentage 
observed in control cultures, suggesting that non-proliferating B cells have an increased survival in IL-6-treated 
Figure 5. Differential effects of IL-6 and LPS on antigen presenting properties of IgM+ B cells. Spleen 
leukocytes were incubated with IL-6 (200 ng/ml), LPS (100 μ g/ml) or control media alone for 24, 48 and 72 h at 
20 °C. The levels of MHC-II expression on the surface of IgM+ B cells were then measured via flow cytometry 
using a specific mAb against trout MHC-II. (a) MFI + standard deviation from 6 independent experiments.  
* P < 0.05, * * P < 0.01, * * * P < 0.001. Representative histogram from one experiment shown below. (b) Spleen 
leukocytes were incubated with IL-6, LPS or control media alone for 24 h at 20 °C. The effect of IL-6 and LPS on 
the transcription of CD80/86 and CD83 co-stimulatory molecules was then studied in sorted IgM+ cells from 
these cultures. The relative transcript expression (mean + standard deviation) of 5 independent experiments is 
shown. * P < 0.05, * * P < 0.01.
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cultures, even higher than that observed in LPS-treated cultures. In mammals, while some authors have reported 
a proliferative effect of IL-6 on pre-activated B cells50, other researchers have described stimulation of Ig secretion 
in the absence of proliferative responses51,52. However, even in those cases where proliferating effects have been 
reported, they seem to be associated only with previously activated cells and are never seen in unstimulated B 
cells. Although it could be possible that some of the B cells in our cultures have been previously exposed to an 
antigen, it seems unlikely that all the B cells responding in our experiments are pre-activated cells given the fact 
that these cells express IgD on the cell membrane and transcribe surface IgM and IgD at high levels (data not 
shown). On the other hand, even though we stimulated B cells in cultures in which other cells were present dur-
ing the incubation period, we have demonstrated that STAT3 is phosphorylated in IgM+ B cells incubated with 
IL-6 in the absence of other cell types. Likewise, it should be noted that there was no significant proliferation of 
IgM− cells in these cultures (Fig. 1c) and that even if IgM+ B cells already accounted for approximately 30% of the 
leukocyte population in the spleen, this percentage was increased to approximately 50% in IL-6-treated cultures 
after 4 days. All the evidence points to a preferential effect of IL-6 on a quite abundant population of B cells within 
the spleen of unstimulated fish. In addition to these experiments in which leukocytes were treated with IL-6 
alone, we also determined the effect of IL-6 on the B cell proliferation induced by antigen encounter, and again 
observed stimulatory effects. These synergistic effects were visualized in response to either TD (TNP-KLH) or TI 
(TNP-LPS) antigens, unlike the situation in mammals where IL-6 only seems to promote TD responses17,18. Thus, 
trout IL-6 has positive effects on proliferation and survival of B cells stimulated with TD antigens, and in contrast 
to mammalian IL-6, it also has mitogenic effects on trout naïve B cells and cells activated with TI antigens.
IL-6 was originally reported as a cytokine capable of inducing antibody production in B cell lines, augmenting 
the secretion of both IgM and IgG on Epstein-Barr virus transformed B cells51,52. However, later reports demon-
strated a preferential effect of IL-6 on switched antibody isotypes, given the fact that IL-6 only plays a role in 
Figure 6. IL-6 has no effect on the phagocytic capacity of IgM+ B cells. Splenocytes were cultured in the 
presence of IL-6 (200 ng/ml) or LPS (100 μ g/ml) for 24, 48 or 72 h at 20 °C. Non-stimulated controls were 
also included. After the different incubation periods, cells were exposed to fluorescent beads for a further 
3 h at 20  °C. Non-ingested beads were removed by centrifugation over a cushion of 3% (w/v) BSA in PBS 
supplemented with 4.5 (w/v) D-glucose (Sigma). (a) Data are shown as mean percentage of phagocytic IgM+  
B cells (left) or Mean fluorescence intensity (MFI) (right) + standard deviation from six independent fish.  
* P < 0.05, * * P < 0.01. (b) Representative dot plots for each condition.
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the terminal differentiation of antigen-experienced B cells15. Thus, IL-6 over-expression in mice provokes IgG 
plasmacytosis, but has no effects on plasma cells of other Ig isotypes53,54. Likewise, IL-6-deficient mice showed 
reduced antigen-specific IgG1, IgG2a and IgG3 levels after immunization with a TD antigen, but IgM levels were 
unaffected17. IL-6 also supports the differentiation of IgA-secreting plasma cells in different mucosal surfaces55,56. 
Teleost fish do not express IgG, IgA or IgE and rely on non-switched IgM, IgD and IgT responses to fight infec-
tions. In this context, trout IL-6 was capable of inducing IgM secretion in spleen B cells, at a level comparable 
Figure 7. Synergistic effects of IL-6 on antigen-induced in vivo IgM production. Rainbow trout were 
injected i.p. with 100 μ l of PBS, 100 μ l of PBS with IL-6 (100 ng/fish), 100 μ l of PBS with 2 × 1010 TCID50/ml 
inactivated IPNV, or 100 μ l of PBS containing the same amount of IPNV and IL-6. (a) The number of IgM 
secreting cells was evaluated at days 2, 6 and 15 post-injection in spleen and kidney leukocyte cultures by 
ELISPOT as described in the Materials and methods section (mean + standard deviation; n = 6). Asterisks 
indicate significant differences between groups as indicated. * P < 0.05. (b) Total IgM, IPNV-specific and natural 
(BSA; galactosidase; PC, phosphorylcholine; and poly I:C-specific) IgM titers were measured in the sera of 
fish killed at day 15 post-immunization by ELISA. Results are shown as absorbance at 405 nm (for total IgM) 
or absorbance at 492 nm (for specific IgMs) for individual fish. Bars indicate mean values in each group and 
asterisks denote significant differences between groups as indicated. * P < 0.05.
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to that induced by LPS. This increased IgM secretion in response to IL-6 was evidenced in ELISPOT and flow 
cytometry and the fact that these IL-6 stimulated cells increased in size and up-regulated Blimp1 further supports 
our observations indicating that trout IL-6 has the capacity to induce the differentiation of unstimulated B cells to 
IgM ASCs. Interestingly, LPS also provoked a size increase and augmented IgM secretion but without induction of 
Blimp1, suggesting that either LPS exerts its activity on a different B cell population to IL-6 or alternatively it acts 
on the same population but drives them towards a different activation state. In mammals, B2 cells differentiate 
into ASCs in response to LPS along with Blimp1 up-regulation, however, there is some controversy as to whether 
B1 cells require Blimp1. While some studies revealed that mammalian B1 cells secrete IgM independently of 
Blimp157, the IgM production by B1 cells in Blimp1-deficient animals was inhibited, suggesting the requirement 
of Blimp1 for normal IgM production58.
To further study the effects of IL-6 on IgM secretion, we performed additional experiments in vivo. Here again, 
the in vivo administration of IL-6 alone significantly increased the number of IgM-secreting cells in the spleen 
at day 2 post-injection. This effect was not observed in the kidney and was lost in the spleen at later sampling 
points, revealing a tissue-specific transitional effect. In mammals, some of the positive effects that IL-6 has on 
IgG expression are also transitional, since IL-6 is required for the normal induction, but not for the maintenance 
of plasma cell responses in vivo because the effects of different survival factors are redundant59. Additionally, 
we studied how IL-6 affected the antibody response elicited by the injection of an IPNV vaccine, observing that 
although IPNV by itself was unable to induce a significant IgM response, when combined with IL-6, the number 
of IgM-secreting cells in the spleen or head kidney significantly increased in comparison to fish immunized 
with IPNV alone. Although the stimulatory effect on the number of IgM-secreting cells was no longer visible at 
day 15 post-injection, at this point we could still see a synergistic effect of IL-6 on the amount of IPNV-specific 
antibodies in serum. While total IgM levels were not significantly higher in fish injected with IPNV and IL-6, 
the increase in the amount of IPNV-specific IgM went along with a significant decrease in the quantity of IgM 
with alternative specificities, such as BSA- or galactosidase-specific IgM. Increases in antigen-specific IgG titers 
with constant total IgG titers have also been reported in humans and the authors postulated that specific IgG 
levels were increased without having an effect on total IgG titers because the ratio of antigen-specific cells was 
very low in relation to the total pool of B cells60. Similarly, it seems that trout IL-6, when combined with IPNV, 
increases IgM secretion of a discrete number of B cells with no effect on overall IgM production. Furthermore, 
it seems that the negative effect of IL-6 on the production of natural antibodies is a conserved effect, as antibod-
ies against phosphorylcholine and LPS are increased in IL-6 gene knockout mice20. Taken together, our results 
clearly demonstrate that IL-6 is able to enhance antigen-specific IgM responses in fish as observed in mammals 
for switched Ig isotypes17,53,55,56.
When mammalian B cells start their differentiation towards plasma cells, a secretory switch in the mRNA pro-
vokes the down-regulation of surface Ig and an increase of secreted Ig, resulting in the lack of BCR once the cells 
are fully differentiated40. However, recent studies have demonstrated that whilst this phenomenon occurs in IgG 
plasma cells it is not seen in IgM or IgA-secreting plasma cells, as the latter preserve a functional BCR in the cell 
surface even if fully differentiated41. Similarly, we observed that the IL-6- or LPS-induced differentiation of trout 
B cells to IgM ASCs was not associated with a decrease in surface IgM levels. As hypothesized in mammals41, the 
presence of a functional BCR on IgM ASCs would allow them to respond directly to their specific antigen upon 
secondary encounters, unlike IgG ASCs. The fact that IL-6 and LPS-activated B cells retain a functional BCR, 
despite their differentiation to ASCs was confirmed by the mobilization of intracellular calcium in response to 
anti-IgM cross-linking. Interestingly, these stimulated cells mobilized intracellular calcium at levels significantly 
higher than control B cells, demonstrating that IL-6 and LPS predispose B cells to a posterior signaling through 
the BCR despite their differentiation to ASCs. This is the first time such an effect is reported for IL-6 in B cells and 
consequently it would be interesting to determine the effect of mammalian IL-6 on BCR signaling in IgM- and 
IgA-secreting plasma cells.
The transcription factor NF-κ B is critically involved in many cellular processes such as inflammation, immune 
response, proliferation or apoptosis61. In our experiments, we have established that IL-6 and LPS canonically 
activate NF-κ B in IgM+ B cells from unstimulated fish. In mammals, BCR cross-linking, CD40 ligation62 or stim-
ulation with LPS or phorbol ester63 have been shown to activate NF-κ B in B cells. However, to our knowledge, 
this is the first report of IL-6-mediated NF-κ B activation in B cells, although IL-6 has been shown to activate this 
transcription factor in epithelial cells43. As a consequence of NF-κ B activation, different immune genes should 
be transcriptionally up-regulated. However, only LPS induced the transcription of typically NF-κ B-regulated 
genes such as IL-1β , IL-8 and TNF-α , suggesting that although IL-6 activated cells translocate p65 to the nucleus, 
additional cellular mechanisms modify the downstream effects. Of course, the up-regulation of IgM synthesis 
observed in IL-6-stimulated B cells could be regulated by NF-κ B as the promoter of the IgM light chain is one of 
the main targets for NF-κ B in mammals64. Since it is known that different NF-κ B components can be activated 
through a variety of mechanisms with different downstream effects61, it seems possible that IL-6 and LPS are 
modulating distinct NF-κ B activation pathways, and this should be studied further.
As trout IL-6 induced the transcription of several antimicrobial peptides in trout macrophages29 and taking 
into account that B cells in fish have antimicrobial properties associated to their phagocytic activity9, we also 
studied the effect of IL-6 and LPS on CATH-1, CATH-2 and hepcidin transcription. While CATH-1 and CATH-2 
were up-regulated by LPS, IL-6 only up-regulated CATH-2, as occurred in macrophages29. Despite the fact that 
IL-6 modulates hepcidin transcription in macrophages29, IL-6 had no effects on hepcidin expression in IgM+ B 
cells. Nevertheless, these results highlight the potent antimicrobial properties of fish B cells. Similar to other anti-
gen presenting cells, B cells express MHC II on the cell surface. Thus, we determined the effects of IL-6 and LPS 
on MHC II surface expression levels and the phagocytic capacity of trout B cells. Again the effects exerted by IL-6 
and LPS were quite different, all of them summarized in Table 1. While IL-6 significantly down-regulated MHC-II 
surface expression on B cells, as expected in an ASC65, LPS provoked a significant up-regulation of MHC-II 
www.nature.com/scientificreports/
1 1Scientific RepoRts | 6:30004 | DOI: 10.1038/srep30004
expression and increased mRNA levels of the co-stimulatory molecules CD80/86 and CD83. The activation of 
IL-6/STAT3 also induces the suppression of antigen presentation in human dendritic cells66. In contrast, and as 
seen in our studies, mammalian B cells stimulated with LPS up-regulate MHC-II surface expression together 
with co-stimulatory molecules (CD86, CD40)67 and plasma cells differentiated in response to TI antigens retain 
MHC-II expression and a functional antigen presenting machinery68. Thus, it seems that plasma cells generated 
in response to LPS or other TI antigens, are not exclusively specialized in antibody secretion and still play a role 
in other immune functions such as antigen presentation and pathogen clearance, and in line with this hypothesis, 
LPS provoked a slight but significant increase in the number of phagocytic B cells in the spleen cultures. This 
increase was observed from 24 to 72 h post-treatment, whereas IL-6 had no effect. Since mammalian B1 cells are 
also phagocytic, it would be interesting to determine if LPS is capable of increasing their phagocytic capacity.
Overall our results demonstrate that in contrast to mammals, fish IL-6 can trigger unstimulated B cells to 
initiate their differentiation towards ASCs. Consequently, trout IL-6 has mitogenic effects on IgM+ cells and these 
proliferating cells increase in size, augment their secretion of IgM, up-regulate Blimp1 and decrease their surface 
MHC-II expression. On the other hand, LPS shows a potent mitogenic activity and increases the secretion of IgM, 
while driving the cells towards a quite different profile that predicts additional functions such as increased anti-
gen presentation (given the increased MHC-II surface expression, up-regulated transcription of co-stimulatory 
molecules and higher phagocytic activity) and a pro-inflammatory role (through the up-regulation of IL-1ß, IL-8 
and TNF-α ). These results highlight that IgM secretion can be induced through quite distinct differentiation 
pathways in fish.
Methods
Animals. Healthy specimens of female rainbow trout (Oncorhynchus mykiss) of approximately 50–70 g were 
obtained from Centro de Acuicultura El Molino (Madrid, Spain). Fish were maintained at the Animal Health 
Research Center (CISA-INIA) laboratory at 14 °C with a re-circulating water system and 12:12 h light:dark photo-
period. Fish were fed twice a day with a commercial diet (Skretting, Spain). Prior to any experimental procedure, 
fish were acclimatized to laboratory conditions for 2 weeks and during this period no clinical signs were ever 
observed. The experiments described comply with the Guidelines of the European Union Council (2010/63/
EU) for the use of laboratory animals and were previously approved by the Ethics committee from the Instituto 
Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA; Code CEEA 2011/044).
Leukocyte isolation. Rainbow trout were killed via benzocaine (Sigma) overdose and blood was extracted 
with a heparinized needle from the caudal vein and diluted 10 times with Leibovitz medium (L-15, Life 
Technologies) supplemented with 100 I.U./ml penicillin, 100 ug/ml streptomycin (P/S), 10 units/ml heparin and 
5% fetal calf serum (FCS) (all supplements also obtained from Life Technologies). Spleen and kidney were col-
lected and single cell suspensions generated using 100 μ m nylon cell strainers (BD Biosciences). Blood cell sus-
pensions were placed onto 51% Percoll (GE Healthcare) cushions whereas kidney and spleen suspensions were 
placed onto 30/51% discontinuous density gradients. All suspensions were then centrifuged at 500 × g for 30 min 
at 4 °C. The interface cells were collected and washed twice with L-15 containing 5% FCS.
Immune function IL-6 LPS
STAT3 transcription Up-regulated Up-regulated
SOCS3 transcription Up-regulated No effect
STAT3 phosphorylation Activated Activated
Mitogenic effects Significant Very significant
IgM secretion Increased Increased
mIgM expression Increased Increased
Total IgM expression Increased Increased
Blimp1 transcription Up-regulated No effect
ACKR2 transcription Up-regulated No effect
p65 translocation to nucleus Yes Yes
IL-1β transcription No effect Up-regulated
IL-8 transcription No effect Up-regulated
TNF-α transcription No effect Up-regulated
CATH1 transcription No effect Up-regulated
CATH2 transcription Up-regulated Up-regulated
Hepcidin transcription No effect No effect
BCR signaling to anti-IgM Increased Increased
MHC-II expression Decreased Increased
Phagocytic activity No effect Increased
CD80/86 transcription No effect Up-regulated
CD83 transcription No effect Up-regulated
Table 1.  Summary table comparing the effects of IL-6 and LPS on trout spleen IgM+ B cells.
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Production of rainbow trout recombinant IL-6. The sequence encoding the mature peptide of trout IL-669 
was amplified from spleen cDNA prepared from Aeromonas salmonicida infected fish70 and cloned to the pET/
Duet-1 vector (Novagen, UK). The N-terminal ATG (M) codon and a C-terminal His tag (GSGHHHHHHHHHH) 
were incorporated from the vector for translation initiation and for purification of the recombinant protein. Thus, 
the rtIL-6 had 211 amino acids, with a predicted molecular weight of 23.8 kDa and pI of 7.27. Sequence analysis 
of three clones (pET/IL-6a, b, c) revealed that they were identical but differed by four nucleotides, of which two 
resulted in two amino acid changes from the published IL-669, presumably due to polymorphism. The sequence has 
been submitted to EMBL/GenBank/DDBJ databases under the accession number FR715329. A plasmid was used to 
transform BL21 Star (DE3) competent cells (Invitrogen) and protein expression was induced by IPTG and purified 
under denaturing conditions as described previously71. The purified, denatured rtIL-6 was refolded in refolding 
buffer containing 50 mM Tris–HCl, pH8.0, 0.5 M arginine, 0.5% Triton-100 and 5 mM β -mercaptoethanol at 4 °C for 
2 days. The refolded rtIL-6 was repurified under native conditions and eluted at concentrations of up to 0.5 mg/ml. 
LPS contamination was checked by examining the expression of a number of LPS-responsive genes, including 
IL-1β , TNF-α , IL-8, IL-10 and IL-11, and by undertaking the Limulus amoebocyte lysate assay (Sigma) as per the 
manufacturer’s instructions.
Cell stimulation. Total leukocyte populations were dispensed in 24-well plates at a density of 2 × 106 cells per ml 
and incubated with the appropriate stimulus: recombinant trout IL-6 (200 ng/ml), LPS (100 μ g/ml; > 95% purity) 
(Sigma), TNP-KLH (5 μ g/ml) (Biotools), TNP-LPS (5 μ g/ml) (Biotools) or anti-IgM Ab (2 μ g/μ l) (clone 1.14)72 at 
concentrations previously optimized. Non-stimulated controls were always included. Cells were always incubated 
at 20 °C for different periods of time depending on specific experiments.
Cell sorting. IgM+ B cells were sorted from spleen, blood or kidney leukocyte suspensions using a BD FACSAria 
III (BD Biosciences) cell sorter. For this, leukocytes were incubated for 30 min on ice with an anti-trout IgM mAb 
(1.14) coupled to phycoerythrin (PE) in Staining buffer (PBS containing 1% FCS and 0.5% sodium azide) that 
prevents cell activation. Following two washing steps, cells were resuspended in FACS buffer and IgM+ B cells iso-
lated based on their FSC/SSC profiles (to exclude the granulocyte gate) and then on the basis of the fluorescence 
emitted by the anti-trout IgM antibody. IgM+ and IgM− cells were then collected in Trizol for subsequent RNA 
isolation.
Real time PCR analysis of sorted cells. Total RNA was isolated from IgM+ sorted populations using 
Tri-reagent (Life Technologies). The cDNA synthesis and real-time PCR analysis were performed as described 
previously33,71. The primers (Supplementary Table S1) for real-time-PCR were designed so that at least one primer 
crossed an intron, to ensure that genomic DNA could not be amplified under the PCR conditions used. The 
expression level of each gene was first normalized against the expression level of EF-1α and then expressed as a 
fold change that was calculated as the average expression of the IL-6/LPS stimulated samples divided by that of 
the controls.
Detection of phosphorylated STAT3. To confirm the phosphorylation of STAT3 in IL-6 and LPS-treated 
B cells and demonstrate direct effects on IgM+ B cells, we first sorted IgM+ cells from splenocyte cultures as 
described above and then incubated them with the different stimuli in the absence of other cell types. For this, 
sorted cells adjusted to 2 × 106 cells per ml were disposed in 96 well plates and incubated with IL-6 (200 ng/ml), 
LPS (100 μ g/ml) or media alone for 1 h at 20 °C. After the incubation, cells were lysed using RIPA buffer contain-
ing protease inhibitors (Roche). Proteins were fractionated onto a denaturing 12% SDS-PAGE gel and transferred 
onto a polyvinylidene difluoride (PVDF) membrane (Immobilon-P; Millipore Merck). After blocking in PBS with 
5% skim milk for 1 h, the membrane was incubated with a mAb against phospho-STAT3 (Ser727) (Santa Cruz 
Biotechnology) in blocking solution at 4 °C overnight. After three washing steps, the membrane was incubated 
for 1 h with the secondary antibody, a goat anti-mouse IgG-HRP conjugate (GE Healthcare Life Sciences). The 
reactive bands were visualized with the ECL system (GE Healthcare Life Sciences).
B cell proliferation. The BrdU Flow Kit (Becton Dickinson) was used to measure the proliferation of IgM+ 
cells following manufacturer’s instructions. Splenocytes at a concentration of 2 × 106 cells per ml were incubated 
for 3 days at 20 °C with the different stimuli as described above. Bromodeoxyuridine (BrdU, 10 μ M) was then 
added to the cultures and the cells were incubated for an additional 24 h. After that time, trout cells were collected 
and stained with anti-IgM-PE (1.14) antibody and then fixed and permeabilized with Cytofix/Cytoperm Buffer 
for 15 min on ice. Afterwards, cells were incubated with Cytoperm Permeabilization Buffer Plus for 10 min on ice 
and re-fixed with Cytofix/Cytoperm Buffer for 5 min at RT. Cells were then incubated with DNase (30 μ g/106 cells) 
for 1 h at 37 °C to expose the incorporated BrdU. Finally, cells were stained with FITC anti-BrdU antibody for 
20 min at RT and analysed by flow cytometry (BD FACSCalibur, BD Biosciences).
ELISPOT analysis. ELISPOT was used to quantify the number of IgM-secreting B cells. For this, ELISPOT 
plates containing Inmobilon-P membranes (Millipore) were activated with 70% ethanol for 30 s, coated with 
anti-trout IgM mAb (clone 4C10) at 2 μ g/ml in PBS and incubated overnight at 4 °C. To block non-specific bind-
ing to the membrane, plates were then incubated with 2% bovine serum albumin (BSA) in PBS for 2 h at RT. 
Stimulated (with IL-6 or LPS as a positive control) or unstimulated splenocytes from individual fish were added 
to the wells in triplicate at a concentration of 1 × 105 cells per well. After 72 h of incubation at 20 °C, cells were 
washed away 5 times with PBS and plates were blocked again with 2% BSA in PBS for 1 h at room temperature. 
After blocking, biotinylated anti-trout IgM mAb (clone 4C10) was added to the plates and incubated at 1 μ g/ml for 
1 h at RT. Following additional washing steps (5 times in PBS) the plates were developed using streptavidin-HRP 
(Thermo Scientific) at RT for 1 h, washed again with PBS and incubated with 3-amino 9-ethylcarbazole (Sigma 
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Aldrich) for 30 min at RT in the dark. Substrate reaction was stopped by washing the plates with tap water. Once 
the membranes had dried, they were digitally scanned and spot counts determined by the ImmunoSpot Series 45 
Micro ELISPOT Analyzer.
Determination of total IgM levels. To determine total (both intracellular and extracellular) IgM levels, 
cells were fixed for 5 min with 4% paraformaldehyde in PBS, then permeabilized for 30 min in permeabilizitation 
buffer (staining buffer containing 0.1% saponin) and thereafter incubated with an anti-IgM-PE antibody in per-
meabilization buffer for another 30 min. After incubation, cells were washed three times with staining buffer and 
analyzed by flow cytometry.
NF-kB activation. Trout splenocytes were isolated and seeded in complete MGFL-15 medium (MGFL-15 
supplemented with P/S, 100 μ g/ml gentamicin, 10% newborn calf serum (Gibco) and 5% carp serum). Cells were 
incubated for 24 h with complete media containing IL-6, LPS or control media alone. Following stimulation, 
cells were fixed in 1% formaldehyde, and washed twice in PBS with 2% calf serum and 0.1% saponin (perme-
abilization buffer). To determine nuclear translocation in IgM+ cells, splenocytes were stained with anti-p65 
(Santa Cruz Biotechnology) and anti-trout IgM (1.14) for 30 min at 4 °C followed by 20 min at RT. Following the 
primary staining, cells were washed and stained with goat anti-rabbit APC (Jackson ImmunoResearch) and rab-
bit anti-mouse FITC (Jackson ImmunoResearch). Prior to acquisition, Hoechst33342 nuclear stain (Molecular 
Probes) was added as per the manufacturer’s recommendations. Data were collected on an ImageStream MKII 
and analyzed using IDEAS software (Amnis), as described previously11.
Analysis of MHC-II expression. The levels of MHC-II expression on the surface of IgM+ B cells were 
measured via flow cytometry using a mAb against trout MHC-II73. Stimulated or unstimulated splenocytes were 
washed in Staining Buffer and co-incubated with PE-conjugated anti-trout IgM and the Alexa 647-conjugated 
anti-MHC-II antibody for 30 min at 4 °C protected from light. Finally cells were washed twice with the same 
buffer and analysed by flow cytometry.
Phagocytic activity. Purified splenocytes (2 × 106) were cultured in 1 ml/well in 24-well plates in the pres-
ence or absence of IL-6 or LPS for 24, 48 or 72 h. After each time point, cells were incubated for 16 h at 20 °C 
with fluorescent beads (FluoSpheres Microspheres, 1.0 μ m, Crimson Red Fluorescent 625/645, 2% solids; Life 
Technologies) at a cell/bead ratio of 1:10 or without beads as negative controls. Non-ingested beads were removed 
by centrifugation (100 × g for 10 min at 4 °C) over a cushion of 3% (w/v) BSA (Fraction V; Fisher Scientific) in 
PBS supplemented with 4.5 (w/v) D-glucose (Sigma). Afterwards, cells were resuspended in staining buffer, labe-
led with PE-anti-IgM mAb (30 min at 4 °C), washed with the same buffer and analyzed by flow cytometry.
Calcium flux. For calcium flux analysis, the calcium indicator Fluo-3 AM (Life Technologies) was used, fol-
lowing the manufacturer’s instructions. Briefly, Fluo-3 was dissolved in DMSO and further diluted in an equal 
volume of 20% (w/v) Pluronic F-127 (Life Technologies). Splenocytes were cultured in the presence or absence 
of LPS or IL-6 during 24, 48 or 72 h. After each time point, cells were diluted in L-15 medium without FCS and 
incubated with Fluo-3 AM at a final concentration of 5 μ M for 1 h. Cells were then collected and washed, and a 
baseline reading for 30 s acquired in a FACSCalibur flow cytometer. Then 0.5 μ g/ml of anti-IgM were added to the 
tube, and the emission of fluorescence (525 nm) determined for 180 s in each sample.
Bioactivity of IL-6 in vivo. To assess the bioactivity of rtIL-6 in vivo, rainbow trout of approximately 5–7 g 
were divided into three groups of 24 fish and injected intraperitoneally (i.p.) with 100 μ l of PBS, 100 μ l of PBS with 
IL-6 (100 ng/fish), 100 μ l of PBS containing 2 × 1010 TCID50/ml inactivated IPNV (kindly donated by Professor 
Øystein Evensen), or 100 μ l of PBS with a combination of IPNV and IL-6 at the same concentration as above. At 
days 2, 6 and 15, six trout from each group were killed by benzocaine overdose. Blood was collected from the 
caudal vein to determine antibody concentration and thereafter splenocytes and kidney leukocytes were isolated 
to determine the number of IgM-secreting cells in ELISPOT assays as described above.
Antibody production. Serum samples were obtained after blood clotting at RT for 1–2 h followed by incu-
bation overnight at 4 °C. Afterwards, the clot was centrifuged at 4000 rpm for 10 min and serum samples were 
collected in a new tube that was centrifuged again at 10000 rpm for 10 min. Supernatants were finally collected in 
different tubes and stored at − 20 °C until use. The production of total IgM, IPNV-specific IgM and natural IgM 
antibodies (with reactivity to TNP-BSA, galactosidase, phosphorylcholine and poly I:C) was then established by 
capture ELISA.
To assess total IgM levels, 96-well ELISA plates were coated overnight with 100 μ l of 2 μ g/ml mouse anti-trout 
Ig mAb 4C10. Wells were then blocked with 100 ul of 1% BSA in 1% Tween-20 PBS for 1 h at RT. Plates were 
washed 3 times with PBS-1% Tween-20 and serum samples were diluted 1:100 in PBS-1% BSA and added to the 
wells. Samples were incubated 1 h at RT and washed 3 times in PBS-1% Tween-20. Then, 50 μ l of biotinylated 
4C10 mAb (1 μ g/ml) diluted in blocking buffer were added to the wells and samples incubated for 1 h at RT. After 
three washing steps, plates were incubated with 50 μ l of Streptavidin-HRP (1:2000 in PBS-1% BSA) for 1 h at RT. 
Wells were washed again 3 times and then 50 μ l of TMB substrate (Sigma) were added. Absorbance at OD405 was 
measured in a FLUO Star Omega Microplate Reader.
An ELISA method was also used to measure IPNV-specific antibodies. Plates were coated with 100 μ l of poly-
clonal anti-IPNV antibody diluted at 1:5000 in diluent buffer (1% fat free dry milk-PBS) and incubated overnight 
at 4 °C. Plates were washed 3 times in PBS-0.05% Tween-20 and blocked with 5% fat free dry milk-PBS for 2 h 
at RT. After 3 washing steps, serum samples were diluted at 1:100 in diluent buffer and incubated overnight at 
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4 °C. After that, biotinylated 4C10 mAb and Streptavidin-HRP were used as described before. OPD substrate was 
added to the wells and samples were measured at OD492 nm.
In order to measure the levels of natural IgM antibodies, plates were coated with 100 μ l of 15 μ g/ml of 
TNP-BSA, 10 μ g/ml galactosidase, 20 μ g/ml phosphorylcholine or 20 μ g/ml poly I:C diluted in PBS and incu-
bated overnight at 4 °C. Plates were then blocked with 100 μ l of 1% BSA in 1% Tween-20 in PBS for 1 h at RT. After 
washing steps in PBS-1% Tween-20, the serum samples were diluted 1:100 in PBS-1% BSA and added to the wells. 
Biotinylated 4C10 mAb and Streptavidin-HRP were also used as described in total anti-IgM detection ELISA. 
Finally, OPD substrate was added to the wells and samples were measured at OD492 nm.
Statistical analysis. Statistical analyses were performed using a two-tailed Student’s t test with Welch’s cor-
rection when the F test indicated that the variances of both groups differed significantly. The differences between 
the mean values were considered significant on different degrees, where * means P ≤ 0.05, * * means P ≤ 0.01 and 
* * * means P ≤ 0.005 (GraphPad Prism 4 software).
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